Avutometinib

About

Therapy type: Targeted therapy

Therapy strategy: MEK inhibition, RAF inhibition

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) KRAS p.G12C Low-Grade Serous Ovarian Cancer Avutometinib, Defactinib
Sensitivity (+) KRAS p.G12V Low-Grade Serous Ovarian Cancer Avutometinib, Defactinib